| Literature DB >> 35507168 |
Noridzzaida Ridzuan1, Darius Widera2, Badrul Hisham Yahaya3.
Abstract
The safety and efficacy of mesenchymal stem cells/marrow stromal cells (MSC) have been widely studied. Since they are hypoimmunogenic, MSC can escape immune recognition, thus making them an attractive tool in clinical settings beyond autologous cell-based therapy. Paracrine factors including extracellular vesicles (EVs) released by MSC play a significant role in exerting therapeutic effects of MSC. Since their first discovery, MSC-EVs have been widely studied in an attempt to tackle the mechanisms of their therapeutic effects in various disease models. However, currently there are no standard methods to isolate EVs. Here, we describe a differential centrifugation-based protocol for isolation of EVs derived from human umbilical cord MSC (huc-MSC). In addition, the protocol describes methods for characterization of the EVs using transmission electron microscope, Western blot, and nanoparticle tracking analysis.Entities:
Keywords: Extracellular vesicles; Human umbilical cord; Mesenchymal stem cells
Mesh:
Year: 2022 PMID: 35507168 DOI: 10.1007/978-1-0716-1979-7_18
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745